Mepilex Lite Dressing for radiation skin damage on anal area
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a special wound dressing (Mepilex Lite) to treat skin burns from radiation therapy in patients with rectal cancer. It may help heal the skin around the anal canal more comfortably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rectal cancer
- Your doctor has recommended radiation therapy
- This is your first time receiving radiation and you have developed grade 2 or higher skin irritation (redness, swelling, peeling) in the anal area
- You are 18 years old or older
- You do not have severe allergies to wound dressing materials
- You are able to complete the full radiation treatment without stopping early
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicated enema can help prevent radiation damage to the rectum during pelvic radiotherapy. It may be a good option if you are starting radiation to the pelvis or rectum and are otherwise in good health.
This study is testing a special dressing called Mepilex® Up for people with leg ulcers, foot ulcers, or skin tears. It aims to see how well the dressing works and if it is safe. You may be able to join if you are an adult with a wound of a certain size and drainage level.
This trial tests a shorter course of radiation therapy followed by a combination of chemotherapy, immunotherapy, and a pain-relief medication, compared to the standard approach. It is for people with a certain type of rectal cancer that has not spread.
This trial tests if a special film placed on the skin can reduce radiation side effects in people who have had breast cancer surgery and are now getting radiation therapy.
This trial tests whether a steroid enema (dexamethasone) can help prevent or reduce bowel damage caused by radiation therapy for rectal cancer. If you're starting or recently started radiation for rectal cancer, this may help protect your bowel health.
This trial tests a shorter course of radiation that avoids draining lymph nodes, followed by an immunotherapy drug (PD-1 inhibitor), for people with stage II or III rectal cancer that is mismatch repair proficient (pMMR) or microsatellite stable (MSS). The goal is to see if this approach can shrink tumors while keeping lymph nodes intact.
Hear when a new Rectal Cancer, Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.